COMMUNIQUÉS West-GlobeNewswire

Captain James A. Lovell Federal Health Care Center to Treat Post-Traumatic Stress With Virtual Reality Donated by Nonprofit SoldierStrong
14/07/2026
STAMFORD, Conn., July 14, 2026 (GLOBE NEWSWIRE) -- The Captain James A. Lovell Health Care Center in North Chicago, Illinois, is the country’s latest Department of Veterans Affairs facility to partner with national [...]
Arizona Nonprofit Launches "Ultimate Road Trip" Fundraiser Inspiring Families to Make Memories While Funding Childhood Blindness Research
14/07/2026
Winner will receive a 2026 Thor Axis motorhome, a Ford Bronco Badlands, and $50,000 cash in one of the charity's largest travel adventure prize packages ever. GILBERT, Ariz., July 14, 2026 (GLOBE NEWSWIRE) -- What if [...]
Guardian Initiative Seeks Community and Corporate Sponsors Ahead of September 28 Charity Golf Tournament Benefiting Military, Veterans, First Responders, and Their Families
14/07/2026
With limited time remaining before the event, businesses and community leaders are encouraged to support a mission that delivers life-changing healthcare to those who have dedicated their lives to serving others. San [...]
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
14/07/2026
Real-World Findings Support Long-Term Benefits of Continuous Treatment with LEQEMBI and Provide Important Insights into Treatment Experience Outside of a Clinical Trial Setting TOKYO and CAMBRIDGE, Mass., July 14, 2026 [...]
Gaylord Specialty Healthcare Appoints Dr. Jennifer Russo as Director, Inpatient Acquired Brain Injury Service, Strengthening National Expertise in Stroke and Brain Injury Rehabilitation
14/07/2026
Wallingford, CT, July 14, 2026 (GLOBE NEWSWIRE) -- Gaylord Specialty Healthcare , one of the nation's leading rehabilitation-focused healthcare systems and a recognized destination for stroke rehabilitation and [...]
Applied Biologics Announces Successful Manufacture of First Research Construct for Disease-Modifying Osteoarthritis Gene Therapy Program
14/07/2026
SCOTTSDALE, Ariz., July 14, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the [...]
IBA – Information Réglementée
14/07/2026
Publication effectuée en vertu de l’article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes dans des émetteurs dont les actions sont admises à la négociation sur un marché réglementé et [...]
AscellaHealth Named ACAP Preferred Vendor to Advance Specialty Pharmacy Strategy, Cost Containment and Care Management
14/07/2026
BERWYN, Pa., July 14, 2026 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announces it has been named as a Preferred Vendor [...]
TAP Sleep Care Highlights Breakthrough Case Study on myTAP® Oral Appliance in Journal of Dental Sleep Medicine: Dramatic Two-Night Improvement in Treatment-Resistant OSA
14/07/2026
DALLAS, July 14, 2026 (GLOBE NEWSWIRE) -- TAP Sleep Care ® , a leader in innovative oral appliance therapy for snoring and obstructive sleep apnea (OSA), today announced the publication of a compelling case report [...]
Inner Voyage Recovery Center earns BBB accreditation and A+ rating after eight years serving the Atlanta region
14/07/2026
Woodstock drug and alcohol rehab adds Better Business Bureau accreditation to its existing credentials — a reflection of nearly a decade of transparent, accountable care for individuals and families across Georgia [...]
Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access
14/07/2026
- Dr. Robert J. Kossmann has served as a prominent advocate for kidney disease patients in multiple roles including Executive Vice President and Chief Medical Officer for Fresenius Medical Care North America - - Dr. [...]
Smile Doctors Outpaces First-Half Growth Plan, Nears 600 Locations Nationwide
14/07/2026
Entering its second decade, the nation's largest ortho-focused support organization posts double-digit first-half growth as new orthodontist affiliations, de novo expansion and accelerating adult demand continue to [...]
Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event
14/07/2026
– Expands pipeline with SNDX-4321, a novel, mutant-selective, allosteric EGFR inhibitor designed to address NSCLC patient populations with significant unmet needs – – SNDX-62122, a next-generation menin inhibitor, [...]
SS Innovations Appoints Sarah M. Romano as Chief Financial Officer
14/07/2026
Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth FORT LAUDERDALE, Fla., July 14, 2026 (GLOBE NEWSWIRE) -- via IBN -- [...]
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
14/07/2026
Conexeu Sciences is aiming CXU™ at the largest unclaimed frontier in injectable aesthetics: restoring body fullness at a scale today's fillers were never built to reach. The move builds on the company's completed 12- [...]
SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)
14/07/2026
Sponsors educational summit of leading pediatric AKI health care experts Announces best practices webinar to further advance new treatment options DENVER, July 14, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding [...]
MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia
14/07/2026
Results presented by the LiBBY study team at the Alzheimer’s Association International Conference (“AAIC”) demonstrated statistically significant improvements in agitation symptoms compared with placebo. The LiBBY study [...]
Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD
14/07/2026
Qelbree remains the first novel, non-stimulant ADHD medication approved in over a decade and is the only ADHD treatment with serotonin (5-HT 2C ) pharmacodynamics approved in its FDA product labeling. Qelbree has [...]
Adneuris Therapeutics Grants Exclusive License to Zhejiang Conba Pharmaceutical to Advance Cebranopadol in Greater China
14/07/2026
Agreement Grants Conba Rights for the Development and Commercialization of Cebranopadol for Pain Across Mainland China, Hong Kong, Macao and Taiwan, representing an important step in expanding the global potential of [...]

Pages